Health Care/Hospital

Infinitus and Jiangnan University Establish an Innovation Research Center to Explore the Combination of Chinese Herbal Medicine and Probiotics

GUANGZHOU, China, Aug. 16, 2023 /PRNewswire/ -- On August 10, the signing and inauguration ceremony ofthe Infinitus-Jiangnan University Chinese Herbal + Probiotics Collaborative Innovation Research Center was held at Infinitus Plaza.

2023-08-16 08:00 1847

YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024

Pipeline makes progress towards commercialization as robust demand for YSJA rabies vaccine continues Gross margin increases to 80.3%; balance sheet remains strong GAITHERSBURG, Md., Aug. 15, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biop...

2023-08-16 05:00 3015

YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024

Pipeline makes progress towards commercialization as robust demand for YSJA rabies vaccine continues Gross margin increases to 80.3%; balance sheet remains strong GAITHERSBURG, Md., Aug. 16, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biop...

2023-08-16 05:00 2494

CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo Persistency

The MOU signed by CytoMed and Hangzhou CNK Therapeutics Co., Ltd is the first of several collaborative efforts inNorth Asia.   SINGAPORE, Aug. 15, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore -based biopharmaceutic...

2023-08-16 01:00 1958

Inmagene's OX40 mAb, with an extended half-life and silenced ADCC, enters POC study in Atopic Dermatitis

SAN DIEGO, SHANGHAI and SYDNEY, Aug. 15, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene"), a clinical stage biotechnology company developing innovative and differentiated therapies for immunological and inflammatory diseases, announced that the first patient has been dosed in a glob...

2023-08-15 22:50 1826

CStone Pharmaceuticals Reports 2023 Interim Results and Updates

* The total revenue was RMB 261.5 million for the six months ended June 30, 2023. The sales of pharmaceutical products revenue was RMB 246.9 million, representing a growth rate of 53% compared to the same period last year. Commercial gross profit margin improved from 47% to 59%. * Healthy fin...

2023-08-15 22:33 3151

Everest Medicines' Partner Venatorx Receives FDA Acceptance and Priority Review of New Drug Application for Cefepime-Taniborbactam to Treat Complicated Urinary Tract Infections (cUTI)

SHANGHAI, Aug. 15, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK)'s partner Venatorx Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application (NDA) for cefepime-taniborbactam, an investigational beta-lactam/beta-lactamase in...

2023-08-15 20:19 1725

Former U.S. Representative Patrick J. Kennedy Joins Holmusk as a Strategic Advisor

Kennedy to champion development of measurement standards to improve behavioral health care NEW YORK, Aug. 15, 2023 /PRNewswire/ -- Holmusk , a leading global behavioral health real-world evidence company, today announced that former U.S. Representative and longtime ment...

2023-08-15 20:00 1175

OnCusp Therapeutics Receives FDA Clearance for the Phase 1 Clinical Trial of CUSP06, Targeting Ovarian Cancer and Other Advanced Solid Tumors

NEW YORK, Aug. 15, 2023 /PRNewswire/ -- OnCusp Therapeutics, a biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients worldwide, announced today the clearance of its Investigational New Drug (IND) Applicatio...

2023-08-15 20:00 1049

Hong Kong Department of Health has Approved the Registration Applications for the Uro-G and Uro-V Disposable Cystoscopic System

SHANGHAI, Aug. 15, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that the Government of Hong Kong Specia...

2023-08-15 16:52 1723

Waterdrop's AI-powered Conversational Platform Clinches Top Prize at 2023 Inslab Insurance Technology Innovation Competition

BEIJING, Aug. 15, 2023 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, recently triumphed at Inslab's 2023 Insurance Technology Innovation Competition, garnering the...

2023-08-15 12:53 3294

Leading Asia Pacific Biopharmas Power Digital Engagement with Veeva CRM

Eighteen of the top 20 biopharmas standardize with Veeva to build meaningful customer relationships SINGAPORE, Aug. 15, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that 18 of the top 20 biopharmas inAsia Pacific are using Veeva CRM

2023-08-15 09:00 2482

TB Alliance Announces Partnership with Remington Pharmaceuticals to Commercialize New Therapy for Drug-Resistant Forms of TB in Pakistan

Non-profit drug developer partners with leading manufacturer of medicine in Pakistan NEW YORK, Aug. 14, 2023 /PRNewswire/ -- Non-profit drug developer TB Alliance has granted Remington Pharmaceutical Industries (Pvt.) Ltd. a non-royalty bearing license to market the anti-tuberculosis (TB) medici...

2023-08-14 21:30 1670

Orthopedic brace can help reduce pain from Hallux Valgus - The Footing Health K releases Toe braces!

* Launch of an instrument to correct bunions SEOUL, South Korea, Aug. 14, 2023 /PRNewswire/ -- When the toes are corrected, our entire body shape, starting from the toes, is corrected. The process of correction starting from the toe can be seen as a process of correcting the connection between ...

2023-08-14 20:00 1110

Kelun-Biotech announces that a Phase III clinical trial of core product SKB264 (MK-2870, TROP2-ADC) in patients with unresectable locally advanced, recurrent or metastatic TNBC who have failed second-line or above prior standard of care has met its primary endpoint

CHENGDU, China, Aug. 14, 2023 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. ("Kelun-Biotech", HKEX: 6990.HK) announced today that its innovative TROP2-ADC (SKB264, also known as MK-2870) met the primary endpoint in the randomized, controlled, open-label, multi-center Phase III ...

2023-08-14 12:50 3117

Souper Fond Revolutionises Meal Preparation for Busy Parents with Nourishing Broths

SINGAPORE, Aug. 14, 2023 /PRNewswire/ -- Mealtimes with children can be as stressful for parents as they are for kids. Souper Fond is launching nourishing broths to help parents add essential nutrients to their children's meals. It can be difficult to introduce infants to new foods as their teeth...

2023-08-14 11:16 1544

International Youth Day 2023: Angel Yeast Paves Path for Young Employees, Supporting Sustainable Talent Development

YICHANG, China, Aug. 12, 2023 /PRNewswire/ -- World's leading yeast manufacturer Angel Yeast (SH600298) is celebrating the 23rd International Youth Day onAugust 12 with a commitment to providing a leading platform and opportunities for youth development and continually...

2023-08-12 20:00 7301

Streamlining Generic Drug Immunogenicity Evaluation: EpiVax's "PANDA" Approach

PROVIDENCE, R.I., Aug. 11, 2023 /PRNewswire/ -- EpiVax Inc. announces the publication of results from a research collaboration with the Food and Drug Administration aimed at streamlining generic drug evaluations. The research, initiated in 2018 with a$1M contract spanning two years (HHSF223018186...

2023-08-11 21:14 3040

Neurophth Secures Nearly 95 Million USD in Series C+ Financing for Gene Therapy Clinical Trials

WUHAN, China and SAN DIEGO, Aug. 11, 2023 /PRNewswire/ -- Neurophth Therapeutics, Inc. ("Neurophth"), aChina's leading gene therapy company for ophthalmic diseases, announced the closing of nearly95 million USD in Series C+ financing. The round was co-led by Yangtze River-CMB International Indust...

2023-08-11 21:00 2286

Nano Labs to Announce First Half of 2023 Financial Results on August 15, 2023

HANGZHOU, China, Aug. 11, 2023 /PRNewswire/ -- Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or "Nano Labs"), a leading fabless integrated circuit design company and product solution provider inChina, today announced that it will report its unaudited financial results for the first half of 2023...

2023-08-11 20:00 4502
1 ... 110111112113114115116 ... 806